Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Myriad Genetics Inc (MYGN)

Myriad Genetics Inc (MYGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
New Large-Scale Meta-Analysis Demonstrates Strong Prognostic Performance of Myriad’s Prolaris® Biopsy Test in Localized Prostate Cancer GlobeNewswire - Thu Jul 2, 8:05AM CDT

SALT LAKE CITY, July 02, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces newly published data from the...

MYGN : 5.83 (-4.43%)
RH
1 Unpopular Stock That Should Get More Attention and 2 We Find Risky StockStory - Tue Jun 30, 11:34PM CDT

1 Unpopular Stock That Should Get More Attention and 2 We Find Risky

KO : 83.49 (+1.04%)
RH : 165.35 (-1.77%)
MYGN : 5.83 (-4.43%)
MYGN
Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1 StockStory - Mon Jun 29, 10:31PM CDT

Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1

MYGN : 5.83 (-4.43%)
MYGN
Why Is Myriad Genetics (MYGN) Stock Rocketing Higher Today StockStory - Wed Jun 24, 10:35AM CDT

Why Is Myriad Genetics (MYGN) Stock Rocketing Higher Today

MYGN : 5.83 (-4.43%)
Myriad Genetics Expands Availability of Precise MRD™ for Colorectal, Renal and Breast Cancers, Supported by New Publication GlobeNewswire - Tue Jun 23, 8:05AM CDT

SALT LAKE CITY, June 23, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces expanded availability of Precise...

MYGN : 5.83 (-4.43%)
COHR
1 Cash-Burning Stock with Promising Prospects and 2 Facing Headwinds StockStory - Thu Jun 4, 11:36PM CDT

1 Cash-Burning Stock with Promising Prospects and 2 Facing Headwinds

GH : 160.05 (-2.46%)
MYGN : 5.83 (-4.43%)
COHR : 324.50 (-0.84%)
HLT
3 High-Flying Stocks We’re Skeptical Of StockStory - Wed Jun 3, 11:32PM CDT

3 High-Flying Stocks We’re Skeptical Of

HLT : 335.48 (-0.64%)
LSTR : 209.32 (+0.78%)
MYGN : 5.83 (-4.43%)
Myriad Genetics Names Raj Jampa as New Chief Technology Officer GlobeNewswire - Tue Jun 2, 8:05AM CDT

SALT LAKE CITY, June 02, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announces today the appointment of Raj Jampa...

MYGN : 5.83 (-4.43%)
Myriad Genetics Highlights Data Showing Broad Clinical Utility of Precise MRD Assay at 2026 ASCO Annual Meeting GlobeNewswire - Wed May 27, 8:05AM CDT

SALT LAKE CITY, May 27, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announces it will share data demonstrating the...

MYGN : 5.83 (-4.43%)
Myriad Genetics Launches Prolaris® + AI, the First Prostate Cancer Test to Combine Genomics and Digital Pathology Artificial Intelligence (AI) GlobeNewswire - Tue May 26, 3:05PM CDT

SALT LAKE CITY, May 26, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announces the launch of the Prolaris + AI Test...

MYGN : 5.83 (-4.43%)

Barchart Exclusives

Forget GPUs. Nvidia’s Next AI Gold Mine Could Be Even Bigger. Barchart - Sun Jul 12, 3:01PM CDT
Wall Street sees Nvidia's Vera CPU as a major growth catalyst that could expand its AI leadership beyond graphics chips. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.